Table 4.

Univariate and multivariate logistic regression analyses of baseline variables predicting PD in training set (n = 93).

Factors	Univariate			Multivariate
	OR	95% CI	P Value	OR	95% CI	P Value
Age	0.981	0.945-1.018	0.308
Gender: Male/Female	1.439	0.434-4.773	0.552
AFP (ng/mL):			0.514
<20*
20-400	2.000	0.569-7.028	0.280
>400	1.538	0.560-4.230	0.404
ALT (U/L)	0.998	0.992-1.005	0.629
AST (U/L)	0.999	0.993-1.005	0.773
PT (s)	1.053	0.814-1.362	0.694
ALB (g/L)	1.009	0.932-1.093	0.829
PLT (109/L)	1.001	0.997-1.006	0.592
TBIL (µmol/L)	1.002	0.957-1.050	0.923
BCLC stage: B/C	0.769	0.271-2.184	0.622
ECOG performance:			0.909
0*
1	1.229	0.452-3.342	0.687
2	1.306	0.111-15.299	0.832
Child-Pugh: B/A	1.101	0.308-3.936	0.882
ALBI grade:1/2	0.124	0.044-0.354	<0.001	0.107	0.032-0.359	<0.001
Tumor number: ≥3/<3	1.857	0.746-4.623	0.183
Tumor size (cm)	0.938	0.841-1.046	0.252
Embolus: Present/Absent	1.568	0.615-3.998	0.347
Extrahepatic metastasis: Present/Absent	1.061	0.360-3.132	0.914
LS value of tumor by SWE (kPa)	1.139	1.063-1.222	<0.001	1.148	1.064-1.239	<0.001
LS value of adjacent normal liver tissue by SWE (kPa)	0.999	0.946-1.055	0.962

AFP, α-fetoprotein; ALB, albumin; ALBI, albumin-bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ECOG, Eastern Cooperative Oncology Group; LS, liver stiffness; PD, Progressive disease; PLT, platelet count; PT, prothrombin time; TBIL, total bilirubin; SWE, shear-wave elastography.

*Used as the reference category.

Bold values are values with statistical differences (P value<0.05).